Glaxosmithkline Share News (GSK)

J&J, Glaxo settle U.S. lawsuit over allergy ads

By Nate Raymond NEW YORK, March 30 (Reuters) - GlaxoSmithKline Plc has agreed to settle a lawsuit by Johnson & Johnson accusing it of using false advertising at the start of the U.S. allergy season to grab market share. The settlement was disclosed during a hearing in Manhattan fede

Glaxo Reaches Agreement With UK Government For Meningitis B Vaccine

GSK agrees UK deal for meningitis shot after Novartis stand-off

By Ben Hirschler LONDON, March 29 (Reuters) - GlaxoSmithKline has reached a deal with the British government to supply a new meningitis B vaccine, following a lengthy stand-off over price with the product's previous owner Novartis. Health minister Jeremy Hunt announced the deal on Sun

UPDATE 1-Two experimental Ebola vaccines pass safety test in African trial

(Updates with details of study) By Sharon Begley NEW YORK, March 26 (Reuters) - Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, "appear to be safe" part way through a clinical trial being conducted in Liberia, th

Two experimental Ebola vaccines pass safety test in African trial

NEW YORK, March 26 (Reuters) - Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, "appear to be safe" part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health (NIH) said on Thursday.<

LONDON MIDDAY BRIEFING: Volatility Returns As Saudi Arabia Strikes

AstraZeneca, Glaxo Sign Up For 100,000 Genomes Project Consortium

TOP NEWS: Borse Dubai Sells GBP1.40 Billion Worth Of LSE Shares

Glaxo Gets Approval For Encruse Ellipta, Two Other Products In Japan

LONDON MIDDAY BRIEFING: TSB Banking To Go The Way Of Abbey National

TOP NEWS: Lloyds Agrees To Sabadell's GBP1.7 Billion Purchase Of TSB

LONDON MORNING BRIEFING: CRH And TSB Lead Firm Early Market

FDA Panel Recommends Approval Of GSK Asthma Drug For Adults

UPDATE 2-FDA panel backs Glaxo asthma drug for adults, not adolescents

(Adds details, background, analyst comment, paragraphs 4-13) By Toni Clarke March 19 (Reuters) - GlaxoSmithKline Plc's drug to treat chronic breathing problems is safe and effective enough for adults with asthma to use but not adolescents, an advisory panel to the U.S. Food and Drug A

FDA panel backs Glaxo asthma drug for adults, not adolescents

March 19 (Reuters) - GlaxoSmithKline Plc's drug to treat chronic breathing problems is safe and effective enough to be approved in adults with asthma but not adolescents, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday. The panel voted 16 to 4 that the produ